CHMFL-ABL-053

Overview

CHMFL-ABL-053 (Compound 18a) is a potent, selective, and orally available BCR-ABL , SRC and p38 kinase inhibitor with IC 50 values of 70, 90 and 62 nM against ABL1 , SRC and p38, respectively.

Application

Products | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Signaling Pathways > MAPK/ERK Pathway | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Bcr-Abl | Products > Signaling Pathways > Src | Products > Signaling Pathways > p38 MAPK

Product Information

• Catalog No.: HY-101268
• CAS No.: 1808287-83-3
• Molecular Formula: C28H26F3N7O2
• Molecular Weight: 549.55
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source